Despite some limitations, this meta-analysis suggested that the GSTM1 null genotype was associated with enhanced risk of prostate cancer carcinogenesis, but non-significant association was observed for GSTT1 deletion with prostate cancer risk. The gene discussed is GSTM1; the disease is Familial prostate cancer.